Recent progress on polySarcosine as an alternative to PEGylation: Synthesis and biomedical applications

Mohamed Fawzi Kabil,Hassan Mohamed El-Said Azzazy,Maha Nasr
DOI: https://doi.org/10.1016/j.ijpharm.2024.123871
IF: 6.51
2024-02-04
International Journal of Pharmaceutics
Abstract:Biotherapeutic PEGylation to prolong action of medications has gained popularity over the last decades. Various hydrophilic natural polymers have been developed to tackle the drawbacks of PEGylation, such as its accelerated blood clearance and non-biodegradability. Polypeptoides, such as polysarcosine (pSar), have been explored as hydrophilic substitutes for PEG. pSar has PEG-like physicochemical characteristics such as water solubility and no reported cytotoxicity and immunogenicity. This review discusses pSar derivatives, synthesis, characterization approaches, biomedical applications, in addition to the challenges and future perspectives of pSar based biomaterials as an alternative to PEG.
pharmacology & pharmacy
What problem does this paper attempt to address?